Recent outcome in the field of distamycin-derived minor groove binders

Farmaco

Volumn 55, Issue 3, 2000, Pages 168-173

  Cozzi, Paolo ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Halogenoacrylamides; Distamycin; Minor groove binders; Nitrogen mustards; Tallimustine

Indexed keywords

ACRYLAMIDE DERIVATIVE; BROSTALLICIN; CHLORMETHINE DERIVATIVE; DISTAMYCIN A DERIVATIVE; PNU 151807; PNU 157911; PNU 160666; TALLIMUSTINE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW TOXICITY; CANCER CELL CULTURE; CYTOTOXICITY; DNA ALKYLATION; DNA SEQUENCE; DRUG DNA BINDING; DRUG SELECTIVITY; HUMAN; LEUKEMIA L 1210; NONHUMAN; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; DISTAMYCINS; HUMANS; MECHLORETHAMINE; NUCLEIC ACID SYNTHESIS INHIBITORS;

EID: 0033914399     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-827X(00)00013-6     Document Type: Article

References (21)

1. See e.g. M. D'Incalci, C. Sessa, Exp. Opin. Invest. Drugs 6 (1997) 875-884.
2. See e.g. P.A. Aristoff, in: Advances in Medicinal Chemistry, vol. 2, JAI, 1993, pp. 67-110, and references therein.
3. Pezzoni G., Grandi M., Biasoli G., Capolongo L., Ballinari D., Giuliani F.C., Barbieri B., Pastori A., Pesenti E., Mongelli N., Spreafico F. Br. J. Cancer. 64:1991;1047.
4. Arcamone F., Penco S., Orezzi P.G., Nicolella V., Pirelli A. Nature. 203:1964;1064.
5. Hageboutros A., Mooneyham A., De Maria T., VonHoff D., Vitek L., O'Dwyer P.J., Weiss G.R. Proc. Am. Assoc. Cancer. Res. 35:1994;1467.
6. See e.g. P. Cozzi, N. Mongelli, Curr. Pharm. Des. 4 (1998) 81, and references therein.
7. Punt C.J.A., Humblet Y., Roca E., Dirix L.J., Wainstein R., Polli A., Corradino I. Br. J. Cancer. 73:1996;803.
8. Viallet J., Stewart D., Shepherd F., Ayoub J., Cormier Y., Di Pietro N., Steward W. Lung Cancer. 15:1996;67.
9. Cozzi P., Beria I., Biasoli G., Caldarelli M., Capolongo L., D'Alessio R., Geroni C., Mazzini S., Ragg E., Rossi C., Mongelli N. Biorg. Med. Chem. Lett. 7:1997;2985.
10. Brendel M., Ruffland A. Mutat. Res. 133:1984;51.
11. Sunters A., Springer C.J., Bagshave K.D., Souhami R.L., Hartley J.A. Biochem. Pharmacol. 44:1992;59.
12. L. Giromini, D. Moneta, M. Tammiso, G. Pennella, C. Geroni, G. Mazué, Tenth NCI-EORTC Symposium on New Drugs in Cancer Therapy, Amsterdam, Abstract 203, 1998.
13. Cozzi P., Beria I., Biasoli G., Caldarelli M., Capolongo L., Geroni C., Mongelli N. Biorg. Med. Chem. Lett. 7:1997;2979.
14. See e.g. J.W. Lown, Chemtracts-Org. Chem. 6 (1993) 205.
15. D'Alessio R., Geroni C., Biasoli G., Pesenti E., Grandi M., Mongelli N. Bioorg. Med. Chem. Lett. 4:1994;1467.
16. Marcaini M., Ciró M., Gallinari F., Broggini M., Cozzi P., D'Incalci M. Br. J. Cancer. 80:1999;991.
17. Baraldi P.G., Beria I., Cacciari B., Capolongo L., Cozzi P., Mongelli N., Romagnoli R., Spalluto G. Bioorg. Med. Chem. Lett. 6:1996;1247.
18. I. Beria, M. Caldarelli, L. Capolongo, P. Cozzi, C. Geroni, N. Mongelli, The Eighth Cyprus Conference on New Methods in Drug Design, Limassol, Abstract 40, 1999.
19. P. Cozzi, I. Beria, M. Caldarelli, L. Capolongo, C. Geroni, N. Mongelli, Tenth RSC-SCI Medicinal Chemistry Symposium, Cambridge, UK, 1999.
20. Unpublished results.
21. M. Ciomei, W. Pastori, P. Cozzi, C. Geroni, Proceedings of AACR, Philadelphia, vol. 40, p. 224, Abstract 1490, 1999.